Rapid protection from COVID-19 in nonhuman primates vaccinated intramuscularly but not intranasally with a single dose of a vesicular stomatitis virus-based vaccine
W Furuyama, K Shifflett, AN Pinski, AJ Griffin… - MBio, 2022 - Am Soc Microbiol
The ongoing pandemic of coronavirus (CoV) disease 2019 (COVID-19) continues to exert a
significant burden on health care systems worldwide. With limited treatments available …
significant burden on health care systems worldwide. With limited treatments available …
Rapid Protection from COVID-19 in Nonhuman Primates Vaccinated Intramuscularly but Not Intranasally with a Single Dose of a Vesicular Stomatitis Virus-Based …
W Furuyama, K Shifflett, AN Pinski, AJ Griffin… - Mbio, 2022 - europepmc.org
The ongoing pandemic of coronavirus (CoV) disease 2019 (COVID-19) continues to exert a
significant burden on health care systems worldwide. With limited treatments available …
significant burden on health care systems worldwide. With limited treatments available …
[HTML][HTML] Rapid Protection from COVID-19 in Nonhuman Primates Vaccinated Intramuscularly but Not Intranasally with a Single Dose of a Vesicular Stomatitis Virus …
W Furuyama, K Shifflett, AN Pinski, AJ Griffin… - mBio, 2022 - ncbi.nlm.nih.gov
The ongoing pandemic of coronavirus (CoV) disease 2019 (COVID-19) continues to exert a
significant burden on health care systems worldwide. With limited treatments available …
significant burden on health care systems worldwide. With limited treatments available …
Rapid Protection from COVID-19 in Nonhuman Primates Vaccinated Intramuscularly but Not Intranasally with a Single Dose of a Vesicular Stomatitis Virus-Based …
W Furuyama, K Shifflett, AN Pinski, AJ Griffin… - mBio, 2022 - pubmed.ncbi.nlm.nih.gov
The ongoing pandemic of coronavirus (CoV) disease 2019 (COVID-19) continues to exert a
significant burden on health care systems worldwide. With limited treatments available …
significant burden on health care systems worldwide. With limited treatments available …
Rapid Protection from COVID-19 in Nonhuman Primates Vaccinated Intramuscularly but Not Intranasally with a Single Dose of a Vesicular Stomatitis Virus-Based …
W Furuyama, K Shifflett, AN Pinski, AJ Griffin… - 2022 - agris.fao.org
The ongoing pandemic of coronavirus (CoV) disease 2019 (COVID-19) continues to exert a
significant burden on health care systems worldwide. With limited treatments available …
significant burden on health care systems worldwide. With limited treatments available …
Rapid protection from COVID-19 in nonhuman primates vaccinated intramuscularly but not intranasally with a single dose of a vesicular stomatitis virus-based vaccine.
W Furuyama, K Shifflett, AN Pinski, AJ Griffin… - 2022 - cabidigitallibrary.org
The ongoing pandemic of coronavirus (CoV) disease 2019 (COVID-19) continues to exert a
significant burden on health care systems worldwide. With limited treatments available …
significant burden on health care systems worldwide. With limited treatments available …
Rapid Protection from COVID-19 in Nonhuman Primates Vaccinated Intramuscularly but Not Intranasally with a Single Dose of a Vesicular Stomatitis Virus-Based …
W Furuyama, K Shifflett, AN Pinski, AJ Griffin… - mBio, 2022 - cir.nii.ac.jp
抄録< jats: p> The vesicular stomatitis virus (VSV) vaccine platform rose to fame in 2019,
when a VSV-based Ebola virus (EBOV) vaccine was approved by the European Medicines …
when a VSV-based Ebola virus (EBOV) vaccine was approved by the European Medicines …